查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1456988

全球藥品包裝市場 - 2024年至2029年預測

Global Pharmaceutical Packaging Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022年藥品包裝市值為955.38億美元，複合年成長率為16.94%，到2029年市場規模將達到1344.76億美元。

藥品包裝市場的成長是由對藥物輸送裝置的需求不斷成長、技術進步以及技術進步帶來的包裝成本降低所推動的。此外，對可重複使用和專業包裝的需求不斷成長預計也將推動這一時期的市場成長。此外，隨著全球電子商務和線上購買趨勢的增加，藥品也需要堅固的包裝以確保產品安全。因此，電子商務行業的成長也正在推動預測期內和未來幾年藥品包裝市場的成長。從地區來看，由於技術採用較早，北美預計將佔據最大佔有率，而美國的醫療保健成本是已開發國家中最高的。亞太地區預計將經歷快速成長，特別是由於印度和中國新興經濟體製藥業的成長。由於慢性病的流行以及對有效治療方法藥物的需求不斷增加，預計亞太地區的藥品包裝市場也將成長。此外，世界各地個人健康意識的增強預計將為市場在未來幾年以永續的速度成長提供機會。

塑膠包裝佔有很大的市場佔有率

塑膠因其多功能性、永續性、耐用性和彈性而成為廣泛用於藥品包裝的材料。各種材料的塑膠瓶用於藥品包裝，包括聚氯乙烯、聚乙烯、聚丙烯和聚苯乙烯。該行業用於銷售和儲存的塑膠透明、堅固且重量輕。腸外溶液袋、泡殼包裝、小袋、預填充式注射器和吸入器以及瓶子均採用塑膠包裝。藥品包裝材料必須易於處理、具有化學惰性，並且對水蒸氣的滲透性較低。此外，包裝材料與生物製藥和藥品直接接觸，必須遵守監管機構制定的嚴格規定。

藥品包裝需求不斷成長

包裝面臨來自其他型態包裝的激烈競爭。出於商業目的，製藥業也需要玻璃材料包裝。製藥公司投資藥品包裝的原因有很多，包括可裝載性、破損性和單位成本。為了與其他選擇競爭，製造商正在開發耐用、輕量的藥品瓶。設計和開發合適的藥品包裝對於確保藥品的安全運輸、儲存和分配至關重要。最常用於藥品包裝的材料是塑膠和玻璃。玻璃是首選，因為它易於清洗並且可以讓您看到裡面的東西。

預計北美在預測期內將出現高速成長。

市場佔有率。此外，美國的個人擴大從基於數量的護理轉向基於價值的護理。我們觀察到醫療保健市場動態的變化，從而導致成本更低和患者治療效果更好。人口老化和慢性疾病患者數量增加等人口變化將進一步推動預測期內藥品包裝市場的成長。隨著疾病的高發病率，患者期待有效的治療，從而導致技術和服務的進步，使消費者能夠更好地控制自己的醫療保健。除了與其他已開發地區不同的醫療保健系統之外，針對有意識和好奇的人群開拓有效的醫療保健策略將導致該地區藥品包裝市場在預測期內的成長帶來更好的醫療保健需求。

主要市場推出

  • 2023 年 11 月，以創造和製造環保包裝解決方案而聞名的國際公司 Amcor Plc 與永續聚乙烯領先製造商 NOVA Chemicals Corporate 簽署了合作備忘錄。根據協議，NOVA Chemicals Corporate 將供應用於軟包裝薄膜的機械回收聚乙烯樹脂 (rPE)。
  • 2023 年 7 月，Constantia Flexibles 推出了 REGULA CIRC，這是一種新型冷成型箔基藥品包裝解決方案。這種包裝採用PE密封層取代傳統的PVC，減少了塑膠的用量，增加了鋁的用量。這種最佳化不僅提高了包裝的永續性，而且有利於回收過程中的材料回收。

目錄

第1章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球藥品包裝市場：依原料分類

  • 介紹
  • 塑膠和聚合物
  • 玻璃
  • 紙和紙板
  • 金屬箔
  • 其他

第6章全球藥品包裝市場：依藥品劑量類型

  • 介紹
  • 液體劑量
  • 固態劑型
  • 半固體和加壓產品

第7章全球藥品包裝市場：依包裝類型

  • 介紹
  • 泡殼包裝
  • 預填充注射器
  • 醫療專用袋
  • 管瓶和安瓿
  • 袋和條袋
  • 其他

第8章全球藥品包裝市場：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Amcor plc
  • CCL Industries
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • ONCAP（Precision Concepts International）
  • SVP Global（Klockner Pentaplast）
  • Carl Zeiss Foundation（SCHOTT AG）
  • Enhanced Equity Fund（Aphena Pharma Solutions）
  • Sonoco Products Company
  • Ampersand Capital Partners（Tjoapack LLC）
簡介目錄
Product Code: KSI061610047

The global pharmaceutical packaging market is evaluated at US$95.538 billion for the year 2022 growing at a CAGR of 16.94% reaching the market size of US$134.476 billion by the year 2029.

The growth of the pharmaceutical packaging market is driven by the increasing demand for drug delivery devices, technological advancements, and a reduction in the packaging cost with the advancement in technology. A rise in the demand for reusable and speciality packaging is also expected to bolster the market growth during the given time frame. Additionally, with the growing e-commerce and online purchasing trend worldwide, drugs also need robust packaging keeping in view the safety of the product. Hence, the growing e-commerce industry is also driving the growth of the global pharmaceutical packaging market in the forecast period and in the upcoming years. On the basis of geography, North America is expected to hold a major share owing to the early adoption of technology, and the highest health expenditure of the United States among all the developed regions of the world. While the Asia Pacific region is expected to be the fastest-growing, this is due to the growing pharmaceutical industry, especially in the emerging economies of India and China. Also, with the prevalence of chronic diseases in the APAC region, the market for pharmaceutical packaging is projected to thrive due to the increasing demand for drugs supported by effective treatment procedures. Furthermore, growing health awareness among individuals worldwide is expected to provide an opportunity for the market to grow at a sustainable pace in the upcoming years.

Plastic packaging holds a significant market share

Plastic is a widely used material for pharmaceutical packaging due to its versatility, sustainability, durability, and flexibility. Plastic bottles made of different materials, such as polyvinyl chloride, polyethylene, polypropylene, and polystyrene, are used in pharmaceutical packaging. The plastic used in this industry for marketing and storage is clear, strong, and lightweight. Parenteral solution pouches, blister packs, sachets, prefilled syringes and inhalers, and bottles are all packaged with plastics. Pharmaceutical packaging materials must be easily handled, chemically inert, and have a low permeability to water vapour. Furthermore, packaging materials must adhere to stringent regulations set forth by regulatory bodies because they come into direct contact with biological agents and pharmaceuticals.

Growing need for pharmaceutical packaging

The packaging faces stiff competition from other forms of packaging. For commercial purposes, the pharmaceutical industry is also looking for glass material packaging. Pharma companies invest in pharmaceutical packaging for a variety of reasons, including loadability, breakages, and unit cost. To compete with alternative options, manufacturers are creating sturdy, lightweight bottles for pharmaceuticals. It is imperative to design and develop suitable packaging for pharmaceutical items in order to guarantee the safe transportation, storage, and dispensing of medications-some of which have the potential to save lives. The two materials most frequently used in pharmaceutical packaging are plastic and glass. Glass is usually preferred because of its features that make it easy to clean and allow you to see what's inside.

North America is expected to grow at a high rate during the forecast period.

The global pharmaceutical packaging market is estimated to hold the largest market share owing to the highest health spending in the United States, healthcare services are very expensive, most of the people in the country have medical insurance, and the country does not have a universal healthcare system. Additionally, there is a rising trend in the United States where individuals are moving from volume-based to value-based care. A shift in the healthcare market dynamics is being observed which is further leading to better patient outcomes at lower costs. Changing demographics like an aging population, and a high prevalence of people with chronic diseases are further driving the growth of the pharmaceutical packaging market in the forecast period. With the high prevalence of diseases, patients look forward to effective treatments and this has led to advancements in technology and services providing consumers be in greater control of their own health management. Designing effective healthcare strategies according to the highly aware and curious citizens in addition to the unique healthcare system among the other developed regions has created a need for the provision of better health services emanating from the growth of the global pharmaceutical packaging market in this region during the forecast period.

Market key launches

  • In November 2023, a Memorandum of Understanding (MOU) has been disclosed between Amcor Plc, a well-known international business recognized for its creation and manufacturing of environmentally friendly packaging solutions, and NOVA Chemicals Corporate, a top manufacturer of sustainable polyethene. Under the terms of the agreement, NOVA Chemicals Corporate will supply mechanically recycled polyethylene resin (rPE), which will be used to make flexible packaging films. By utilizing more rPE in flexible packaging applications, this initiative is in line with Amcor's commitment to promoting packaging circularity.
  • In July 2023, Constantia Flexibles unveiled REGULA CIRC, a novel coldform foil-based pharmaceutical packaging solution. The packaging substitutes a PE sealing layer for traditional PVC, which lowers the amount of plastic and increases the amount of aluminium. This optimization boosts material recovery during recycling procedures in addition to improving the packaging's sustainability.

Segmentation:

By Raw Material

  • Plastics and Polymers
  • Glass
  • Paper and Paperboard
  • Metal Foils
  • Others

By Pharmaceutical Dosage Type

  • Liquid Dosage
  • Solid Dosage
  • Semi Solid and Pressurized Products

By Packaging Type

  • Blister Packs
  • Pre-Fillable Syringes
  • Medical Specialty Bags
  • Vials and Ampoules
  • Pouches and Strip Bags
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 5.1. Introduction
  • 5.2. Plastic and Polymers
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Glass
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Paper and Paperboard
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Metal Foils
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Trends and Opportunities
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PHARMACEUTICAL DOSAGE TYPE

  • 6.1. Introduction
  • 6.2. Liquid Dosage
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Solid Dosage
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Semi Solid and Pressurized Products
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE

  • 7.1. Introduction
  • 7.2. Blister Packs
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Pre-Fillable Syringes
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Medical Specialty Bags
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Vials and Ampoules
    • 7.5.1. Market Trends and Opportunities
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness
  • 7.6. Pouches and Strip Bags
    • 7.6.1. Market Trends and Opportunities
    • 7.6.2. Growth Prospects
    • 7.6.3. Geographic Lucrativeness
  • 7.7. Others
    • 7.7.1. Market Trends and Opportunities
    • 7.7.2. Growth Prospects
    • 7.7.3. Geographic Lucrativeness

8. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Raw Material
    • 8.2.2. By Pharmaceutical Dosage Type
    • 8.2.3. By Packaging Type
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Raw Material
    • 8.3.2. By Pharmaceutical Dosage Type
    • 8.3.3. By Packaging Type
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Raw Material
    • 8.4.2. By Pharmaceutical Dosage Type
    • 8.4.3. By Packaging Type
    • 8.4.4. By Country
      • 8.4.4.1. UK
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Raw Material
    • 8.5.2. By Pharmaceutical Dosage Type
    • 8.5.3. By Packaging Type
    • 8.5.4. By Country
      • 8.5.4.1. UAE
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. Saudi Arabia
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Raw Material
    • 8.6.2. By Pharmaceutical Dosage Type
    • 8.6.3. By Packaging Type
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Others
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Amcor plc
  • 10.2. CCL Industries
  • 10.3. Gerresheimer AG
  • 10.4. West Pharmaceutical Services, Inc.
  • 10.5. ONCAP (Precision Concepts International)
  • 10.6. SVP Global (Klockner Pentaplast)
  • 10.7. Carl Zeiss Foundation (SCHOTT AG)
  • 10.8. Enhanced Equity Fund (Aphena Pharma Solutions)
  • 10.9. Sonoco Products Company
  • 10.10. Ampersand Capital Partners (Tjoapack LLC)